BTS Research
BioLegacy Research is a San Diego-based Contract Research Organization providing GLP and Non-GLP preclinical services to clients in pharmaceutical, biopharmaceutical, biotech, academic research, and medical device industries since 2001. They support early discovery in vitro and in vivo programs, mechanism of action studies, efficacy studies in disease models, toxicology, and IND-enabling studies, with expertise in inflammation, oncology, and metabolic diseases. They emphasize regulatory compliance, animal care, and offer state-of-the-art lab space. They also provide specialized services such as SARS-CoV-2 neutralizing antibody assays and advanced molecular imaging.
Industries
Nr. of Employees
small (1-50)
BTS Research
Patents
Products
Preclinical Drug Development Services
Comprehensive preclinical testing services analyzing bioactivity, safety, and efficacy to support drug development and IND, NDA, and EPA submissions for small molecules, large molecules, and biologics.
Custom Services
Tailored preclinical contract research services designed to meet specific client study requirements.
Disease Models
Animal models available to investigate biologics, inflammation, cancer, and metabolic diseases in small and large animals.
Toxicology Services
Expertise in running acute and repeated dose toxicology studies in small and large animals.
Pharmacology Services
Performing efficacy studies in disease models and in vivo pharmacology support in areas such as inflammation, oncology, and metabolic diseases.
Investigational New Drug Process
Performing discovery to IND and NDA enabling studies, including IND-enabling preclinical studies in small and large animals.
Preclinical Drug Development Services
Comprehensive preclinical testing services analyzing bioactivity, safety, and efficacy to support drug development and IND, NDA, and EPA submissions for small molecules, large molecules, and biologics.
Custom Services
Tailored preclinical contract research services designed to meet specific client study requirements.
Disease Models
Animal models available to investigate biologics, inflammation, cancer, and metabolic diseases in small and large animals.
Toxicology Services
Expertise in running acute and repeated dose toxicology studies in small and large animals.
Pharmacology Services
Performing efficacy studies in disease models and in vivo pharmacology support in areas such as inflammation, oncology, and metabolic diseases.
Investigational New Drug Process
Performing discovery to IND and NDA enabling studies, including IND-enabling preclinical studies in small and large animals.
Services
Provision of a broad set of in vitro assays to support discovery, mechanism-of-action studies, assay optimization and to inform in vivo study design.
In vivo pharmacology and efficacy studies to assess efficacy, mechanism-of-action, PK/PD and ADME in disease models across multiple species.
Acute and repeated-dose toxicology studies, including IND-enabling toxicology programs in small and large animals with GLP and non-GLP options.
Support for IND preparation including conduct of IND-enabling studies and regulatory-focused documentation and workflows.
Access to and use of tailored animal disease models for inflammation, oncology, metabolic and other therapeutic areas with disease staging to reduce variability.
Preclinical testing and evaluation services for medical devices including functional performance testing and regulatory-focused assessments.
Provision of a broad set of in vitro assays to support discovery, mechanism-of-action studies, assay optimization and to inform in vivo study design.
In vivo pharmacology and efficacy studies to assess efficacy, mechanism-of-action, PK/PD and ADME in disease models across multiple species.
Acute and repeated-dose toxicology studies, including IND-enabling toxicology programs in small and large animals with GLP and non-GLP options.
Support for IND preparation including conduct of IND-enabling studies and regulatory-focused documentation and workflows.
Access to and use of tailored animal disease models for inflammation, oncology, metabolic and other therapeutic areas with disease staging to reduce variability.
Preclinical testing and evaluation services for medical devices including functional performance testing and regulatory-focused assessments.
Expertise Areas
- Preclinical contract research (CRO) operations
- GLP and non-GLP study execution
- In vitro assay development
- In vivo pharmacology and toxicology
Key Technologies
- Molecular imaging
- SPECT (nuclear medicine imaging)
- Ultrasound imaging with strain analysis
- 3D/4D biodistribution imaging